Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


The aryl ring or aryl ring system is bonded directly to another ring or ring system

Subclass of:

514 - Drug, bio-affecting and body treating compositions

514001000 - DESIGNATED ORGANIC ACTIVE INGREDIENT CONTAINING (DOAI)

514579000 - Nitrogen containing other than solely as a nitrogen in an inorganic ion of an addition salt, a nitro or a nitroso DOAI

514646000 - Benzene ring containing

514649000 - Amino nitrogen attached to aryl ring or aryl ring system by an acyclic carbon or acyclic chain

Patent class list (only not empty are listed)

Deeper subclasses:

Class / Patent application numberDescriptionNumber of patent applications / Date published
514650000 The aryl ring or aryl ring system is bonded directly to another ring or ring system 6
20110301244FAST ACTING NARATRIPTAN COMPOSITION - The present invention relates to pharmaceutical compositions containing Naratriptan, a compound selected from the group consisting of 2-HPOD, 2-HPHM, 4-PPED, 4-BPED and 2-PPED, and optionally, a pharmaceutically acceptable excipient.12-08-2011
20110201690DEUTERIUM-ENRICHED DAPOXETINE - The present application describes deuterium-enriched dapoxetine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.08-18-2011
20090005456PHENYL SUBSTITUTED CYCLOALKYLAMINES AS MONOAMINE REUPTAKE INHIBITORS - Phenyl-substituted cyclohexylamine derivatives and method for their synthesis and characterization are disclosed. Use of these compounds to treat/prevent neurological disorders as well as methods for their synthesis are set forth herein. Exemplary compounds of the invention inhibit reuptake of endogenous monoamines, such as dopamine, serotonin and norepinephrine (e.g., from the synaptic cleft) and modulate one or more monoamine transporter. Pharmaceutical formulations incorporating compounds of the invention are also provided.01-01-2009
20090076163DEUTERIUM-ENRICHED DAPOXETINE - The present application describes deuterium-enriched dapoxetine, pharmaceutically acceptable salt forms thereof, and methods of treating using the same.03-19-2009
20100331424Use of Axomadol for Treatment of Arthrosis Pain - The use of axomadol for the treatment of pain in arthrosis.12-30-2010
20100004341C-(2-Phenyl-Cyclohexyl)-Methylamine Compounds for Therapy of Fibromyalgia - Pharmaceutical formulations of [2-(3-methoxyphenyl)-cyclohexylmethyl]-dimethylamine and the metabolites thereof suitable for treating fibromyalgia or chronic pain due to fibromyalgia, and related methods of treating fibromyalgia or chronic pain due to fibromyalgia are described.01-07-2010

Patent applications in class The aryl ring or aryl ring system is bonded directly to another ring or ring system